fingolimod hydrochloride has been researched along with Brain Ischemia in 24 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (4.17) | 29.6817 |
2010's | 16 (66.67) | 24.3611 |
2020's | 7 (29.17) | 2.80 |
Authors | Studies |
---|---|
Arai, K; Esposito, E; Lee, J; Li, W; Lizasoain, I; Lo, EH; Mandeville, ET; Mandeville, JB; Moro, MÁ; Nakano, T; Park, JH; Quinto-Alemany, D; Waeber, C; Zhang, F | 1 |
Malone, K; Moore, AC; Shearer, JA; Waeber, C | 1 |
He, J; Lin, L; Qin, C; Shang, K; Tian, DS; Wang, W; Wu, LJ; Yang, LL; Zhan, KB; Zhou, LQ; Zou, J | 1 |
Higashikawa, K; Houkin, K; Kawabori, M; Kihara, A; Kuge, Y; Midori, YA; Ohno, Y; Wang, Z; Yasui, H | 1 |
Choi, JW; Gaire, BP | 1 |
Diaz Diaz, AC; Malone, K; Moore, AC; Shearer, JA; Waeber, C | 1 |
Bayat, M; Haghani, M; Naseh, M; Rafati, A; Vatanparast, J | 1 |
Hou, X; Pang, X | 1 |
Campbell, B; Lin, L; Lou, M; Shi, FD; Zhang, M; Zhang, R; Zhang, S; Zhou, Y | 1 |
Fan, WH; Liu, Q; Murugan, M; Qin, C; Shang, K; Tian, DS; Wang, W; Wu, LJ | 1 |
Fan, WH; Li, X; Liu, JL; Qin, C; Tian, DS; Wang, MH | 1 |
Brait, VH; Chamorro, A; Gallizioli, M; Justicia, C; Meissner, A; Miró-Mur, F; Planas, AM; Salas-Perdomo, A; Urra, X | 1 |
Arumugam, TV; Chen, CLH; Choi, YK; Ihara, M; Kinoshita, H; Lim, YA; Maki, T; Saito, S; Takahashi, R; Wong, PT; Yamamoto, Y; Yasuda, K | 1 |
Brede, M; Deppermann, C; Göb, E; Göbel, K; Herrmann, AM; Kleinschnitz, C; Kraft, P; Lorenz, K; Meuth, SG; Nieswandt, B; Pfeilschifter, W; Schuhmann, MK; Stoll, G; Thielmann, I | 1 |
Altay, O; Hasegawa, Y; Rolland, W; Suzuki, H; Zhang, JH | 1 |
Fu, Y; Han, W; Hao, J; Li, YJ; Liu, Q; Ren, L; Shi, FD; Sun, N; Xue, R; Yan, Y; Yu, C; Zhang, N | 1 |
Choi, JW; Chun, J; Han, JE; Jeon, S; Moon, E; Ryu, JH | 1 |
Fluri, F; Kleinschnitz, C; Krstic, M; Schuhmann, MK | 1 |
Czech, B; Huwiler, A; Kahles, T; Mazaheri-Omrani, N; Neumann-Haefelin, T; Pfeilschifter, J; Pfeilschifter, W; Rami, A; Strobel, MA | 1 |
Hasegawa, Y; Rolland, W; Sozen, T; Suzuki, H; Zhang, JH | 1 |
Alsharif, N; Brinkmann, V; Guo, S; Hwang, SK; Kim, HH; Liao, JK; Lo, EH; Qin, T; Shin, HK; Waeber, C; Wei, Y; Yemisci, M; Yung, LM | 1 |
Bauer, H; Liesz, A; Mracsko, E; Schwarting, S; Sommer, C; Sun, L; Veltkamp, R; Zhou, W; Zorn, M | 1 |
Czech-Zechmeister, B; Foerch, C; Huwiler, A; Koch, A; Mirceska, A; Pfeilschifter, J; Pfeilschifter, W; Rami, A; Steinmetz, H; Sujak, M | 1 |
Konoeda, F; Shichita, T; Yoshimura, A | 1 |
3 review(s) available for fingolimod hydrochloride and Brain Ischemia
Article | Year |
---|---|
Sphingosine 1-Phosphate Receptors in Cerebral Ischemia.
Topics: Animals; Brain Damage, Chronic; Brain Ischemia; Clinical Trials as Topic; Disease Models, Animal; Drug Evaluation, Preclinical; Fingolimod Hydrochloride; Humans; Infarction, Middle Cerebral Artery; Inflammation; Ischemic Stroke; Lysophospholipids; Neovascularization, Physiologic; Nerve Tissue Proteins; Neuroprotective Agents; Phosphotransferases (Alcohol Group Acceptor); Rats; Signal Transduction; Sphingosine; Sphingosine-1-Phosphate Receptors | 2021 |
The emerging role of FTY720 as a sphingosine 1-phosphate analog for the treatment of ischemic stroke: The cellular and molecular mechanisms.
Topics: Animals; Brain Ischemia; Endothelial Cells; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Ischemic Stroke; Lysophospholipids; Propylene Glycols; Receptors, Lysosphingolipid; Sphingosine; Stroke | 2021 |
[Role of T lymphocytes in ischemic brain injury].
Topics: Animals; Antibodies, Neutralizing; Brain Ischemia; Corynebacterium; Cytokines; Disease Progression; Fingolimod Hydrochloride; Humans; Inflammation Mediators; Interleukin-17; Interleukin-23; Mice; Molecular Targeted Therapy; Propylene Glycols; Sphingosine; T-Lymphocytes; Time Factors | 2010 |
2 trial(s) available for fingolimod hydrochloride and Brain Ischemia
Article | Year |
---|---|
Rationale and design of combination of an immune modulator Fingolimod with Alteplase bridging with Mechanical Thrombectomy in Acute Ischemic Stroke (FAMTAIS) trial.
Topics: Brain Ischemia; Combined Modality Therapy; Fibrinolytic Agents; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Mechanical Thrombolysis; Reperfusion Injury; Research Design; Stroke; Time-to-Treatment; Tissue Plasminogen Activator | 2017 |
Impact of an immune modulator fingolimod on acute ischemic stroke.
Topics: Adult; Aged; Brain Ischemia; Case-Control Studies; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Lymphocyte Subsets; Male; Middle Aged; Propylene Glycols; Single-Blind Method; Sphingosine; Stroke | 2014 |
19 other study(ies) available for fingolimod hydrochloride and Brain Ischemia
Article | Year |
---|---|
Fingolimod Does Not Reduce Infarction After Focal Cerebral Ischemia in Mice During Active or Inactive Circadian Phases.
Topics: Animals; Brain Edema; Brain Ischemia; Disease Models, Animal; Fingolimod Hydrochloride; Hemorrhage; Infarction, Middle Cerebral Artery; Male; Mice; Mice, Inbred C57BL; Sphingosine; Stroke | 2022 |
The impact of fingolimod on Treg function in brain ischaemia.
Topics: Animals; Brain Ischemia; Fingolimod Hydrochloride; Gene Expression; Interleukin-10; Mice; T-Lymphocytes, Regulatory | 2023 |
Fingolimod promotes angiogenesis and attenuates ischemic brain damage via modulating microglial polarization.
Topics: Angiogenesis Inducing Agents; Animals; Brain; Brain Ischemia; Encephalitis; Fingolimod Hydrochloride; Male; Mice, Inbred C57BL; Microglia; Neovascularization, Physiologic; Neuroprotective Agents | 2020 |
FTY720 Protects Against Ischemia-Reperfusion Injury by Preventing the Redistribution of Tight Junction Proteins and Decreases Inflammation in the Subacute Phase in an Experimental Stroke Model.
Topics: Animals; Apoptosis; Brain Ischemia; Endothelial Cells; Fingolimod Hydrochloride; Inflammation; Organophosphates; Rats, Sprague-Dawley; Sphingosine; Tight Junction Proteins | 2020 |
The effect of fingolimod on regulatory T cells in a mouse model of brain ischaemia.
Topics: Aging; Animals; Brain Ischemia; Diet, High-Fat; Disease Models, Animal; Female; Fingolimod Hydrochloride; Immunosuppressive Agents; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; T-Lymphocytes, Regulatory | 2021 |
Synergistic protective effect of FTY720 and vitamin E against simulated cerebral ischemia in vitro.
Topics: Animals; Antioxidants; Astrocytes; Biomarkers; Brain Ischemia; Cell Survival; Cells, Cultured; Cytokines; Disease Models, Animal; Drug Synergism; Fingolimod Hydrochloride; Inflammation Mediators; Neuroprotective Agents; Rats; Vitamin E | 2017 |
Fingolimod Protects Against Ischemic White Matter Damage by Modulating Microglia Toward M2 Polarization via STAT3 Pathway.
Topics: Animals; Brain Ischemia; Carotid Stenosis; Cell Polarity; Cognitive Dysfunction; Corpus Callosum; Cytokines; Fingolimod Hydrochloride; Macrophage Activation; Memory, Short-Term; Mice; Mice, Inbred C57BL; Microglia; Neuroprotective Agents; Ranvier's Nodes; Signal Transduction; STAT3 Transcription Factor; White Matter | 2017 |
Fingolimod suppresses neuronal autophagy through the mTOR/p70S6K pathway and alleviates ischemic brain damage in mice.
Topics: Animals; Apoptosis; Autophagy; Behavior, Animal; Brain Ischemia; Dose-Response Relationship, Drug; Fingolimod Hydrochloride; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred C57BL; Neurons; Neuroprotective Agents; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; Thrombosis; TOR Serine-Threonine Kinases | 2017 |
Role of the S1P pathway and inhibition by fingolimod in preventing hemorrhagic transformation after stroke.
Topics: Animals; Brain; Brain Ischemia; Fingolimod Hydrochloride; Hemoglobins; Hemorrhage; Lymphocytes; Lysophospholipids; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myeloid Cells; Reperfusion Injury; RNA, Messenger; Sphingosine; Sphingosine 1 Phosphate Receptor Modulators; Sphingosine-1-Phosphate Receptors; Stroke; T-Lymphocytes; Thrombocytopenia; Up-Regulation | 2019 |
Effect of fingolimod on oligodendrocyte maturation under prolonged cerebral hypoperfusion.
Topics: Animals; Brain Ischemia; Cell Differentiation; Disease Models, Animal; Female; Fingolimod Hydrochloride; Male; Mice; Mice, Inbred C57BL; Neurogenesis; Oligodendrocyte Precursor Cells; Oligodendroglia; Phosphatidylinositol 3-Kinases; Primary Cell Culture; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; White Matter | 2019 |
FTY720 ameliorates acute ischemic stroke in mice by reducing thrombo-inflammation but not by direct neuroprotection.
Topics: Animals; Brain Ischemia; Enzyme Inhibitors; Fingolimod Hydrochloride; Homeodomain Proteins; Hypoxia; Immunosuppressive Agents; Inflammation; Lymphocytes; Lymphopenia; Male; Mice; Mice, Transgenic; Middle Cerebral Artery; Neurons; Neuroprotective Agents; Propylene Glycols; Sphingosine; Stroke; Thrombosis | 2013 |
Role of the sphingosine metabolism pathway on neurons against experimental cerebral ischemia in rats.
Topics: Animals; Brain Ischemia; Disease Models, Animal; Fingolimod Hydrochloride; Immunosuppressive Agents; Infarction, Middle Cerebral Artery; Male; Neurons; Phosphotransferases (Alcohol Group Acceptor); Propylene Glycols; Rats; Rats, Sprague-Dawley; Sphingosine | 2013 |
Exogenous S1P Exposure Potentiates Ischemic Stroke Damage That Is Reduced Possibly by Inhibiting S1P Receptor Signaling.
Topics: Animals; Blood-Brain Barrier; Brain Ischemia; Fingolimod Hydrochloride; Lysophospholipids; Male; Mice; Mice, Inbred ICR; Microinjections; Neuroglia; Phosphotransferases (Alcohol Group Acceptor); Receptors, Lysosphingolipid; Signal Transduction; Sphingosine; Stroke; Tumor Necrosis Factor-alpha | 2015 |
Fingolimod (FTY720) Reduces Cortical Infarction and Neurological Deficits During Ischemic Stroke Through Potential Maintenance of Microvascular Patency.
Topics: Animals; Brain; Brain Infarction; Brain Ischemia; Brain-Derived Neurotrophic Factor; Disease Models, Animal; Fingolimod Hydrochloride; Infarction, Middle Cerebral Artery; Male; Mice, Inbred C57BL; Microvessels; Stroke | 2016 |
The immunomodulatory sphingosine 1-phosphate analog FTY720 reduces lesion size and improves neurological outcome in a mouse model of cerebral ischemia.
Topics: Active Transport, Cell Nucleus; Animals; Apoptosis; Apoptosis Inducing Factor; Blood-Brain Barrier; Brain; Brain Ischemia; Fingolimod Hydrochloride; Immunosuppressive Agents; Lysophospholipids; Macrophages; Male; Mice; Mice, Inbred C57BL; Microglia; Neuroprotective Agents; Neutrophils; Propylene Glycols; Sphingosine | 2009 |
Activation of sphingosine 1-phosphate receptor-1 by FTY720 is neuroprotective after ischemic stroke in rats.
Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Brain; Brain Ischemia; Disease Models, Animal; Drug Administration Schedule; Fingolimod Hydrochloride; Immunosuppressive Agents; In Situ Nick-End Labeling; Infarction, Middle Cerebral Artery; Male; MAP Kinase Signaling System; Nerve Degeneration; Neuroprotective Agents; Oxadiazoles; Propylene Glycols; Rats; Rats, Sprague-Dawley; Receptors, Lysosphingolipid; Sphingosine; Stroke; Thiophenes; Treatment Outcome | 2010 |
Fingolimod provides long-term protection in rodent models of cerebral ischemia.
Topics: Animals; Apoptosis; Brain Ischemia; Disease Models, Animal; Fingolimod Hydrochloride; Immunosuppressive Agents; In Vitro Techniques; Inflammation; Mice; Mice, Inbred C57BL; Neurons; Neuroprotective Agents; Neurotoxicity Syndromes; Propylene Glycols; Rats; Receptors, Lysosphingolipid; Sphingosine; Stroke | 2011 |
FTY720 reduces post-ischemic brain lymphocyte influx but does not improve outcome in permanent murine cerebral ischemia.
Topics: Animals; Brain Edema; Brain Ischemia; Fingolimod Hydrochloride; Immunosuppressive Agents; Interleukin-6; Leukocytes; Lymphocytes; Male; Mice; Mice, Inbred C57BL; Propylene Glycols; Sphingosine; Tumor Necrosis Factor-alpha | 2011 |
Activation of sphingosine kinase 2 is an endogenous protective mechanism in cerebral ischemia.
Topics: Animals; Brain Ischemia; Enzyme Activation; Fingolimod Hydrochloride; Gene Deletion; Infarction, Middle Cerebral Artery; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Phosphotransferases (Alcohol Group Acceptor); Propylene Glycols; Sphingosine | 2011 |